Trademark Overview
On Thursday, March 10, 2022, a trademark application was filed for ROXPHARMA with the United States Patent and Trademark Office. The USPTO has given the ROXPHARMA trademark a serial number of 97306607. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, August 1, 2023. This trademark is owned by ROXFARMA LLC. The ROXPHARMA trademark is filed in the Pharmaceutical Products category with the following description:
Analgesics; Laxatives; Allergy medications; Collagen for medical purposes; Dietary and nutritional supplements; Pain relief medication; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of gastro-intestinal disorders, indigestion, stomach pain and to support gastro-intestinal health; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for wounds; Vitamin and mineral supplements; Food supplements; Protein supplements
